Axsome Therapeutics Inc at UBS Global Healthcare Virtual Conference Transcript
Good morning, everyone. Thank you for joining us at the UBS Virtual Healthcare Conference Day 1. I am excited to have Axsome management team here with us for a presentation. And I would love to turn the mic over to Herriot Tabuteau, CEO of Axsome.
Well, thank you so much for having us present at your conference. This is our first year at the UBS conference. And this is an exciting time for Axsome. So this is a great time for us to be presenting. Now while Axsome is a CNS-focused company.
And before I get into that, I just want to go to Slide 2. So I will be making forward-looking statements, and I do encourage you to read our SEC filings for a full description of uncertainties associated with our business.
So as I mentioned, Axsome is CNS-focused. When the company was founded, the point of choosing this therapeutic area was that it was underserved at the time, and
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
